Wei-Jia Fang (Weijia Fang)

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 24

Top Topics

Histone Deacetylase

Top Venues

Nature medicine

Nature materials

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Feng-Hua Wang, Ying Jin, Min Wang, Hui-Yan Luo, Wei-Jia Fang, Ying-Nan Wang, Yan-Xing Chen, Run-Jie Huang, Wen-Long Guan, Weiwei Xiao, Yu-Hong Li, Feng-Hua Wang, Xiao-Hua Hu, Yan-Qiao Zhang, Miao-Zhen Qiu, Lu-Lu Liu, Zi-Xian Wang, Chao Ren, De-Shen Wang, Dong-Sheng Zhang, Zhi-Qiang Wang, Wen-Ting Liao, Lin Tian, Qi Zhao, Rui-Hua Xu
Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial. Nature medicine 30 (4) (2024)
Feng-Hua Wang, Ying Jin, Min Wang, Hui-Yan Luo, Wei-Jia Fang, Ying-Nan Wang, Yan-Xing Chen, Run-Jie Huang, Wen-Long Guan, Weiwei Xiao, Yu-Hong Li, Feng-Hua Wang, Xiao-Hua Hu, Yan-Qiao Zhang, Miao-Zhen Qiu, Lu-Lu Liu, Zi-Xian Wang, Chao Ren, De-Shen Wang, Dong-Sheng Zhang, Zhi-Qiang Wang, Wen-Ting Liao, Lin Tian, Qi Zhao, Rui-Hua Xu
Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial. Nature medicine 30 (4) (2024)
Jiaqi Shi, Wei Wu, Dong Chen, Ziyan Liao, Tao Sheng, Yanfang Wang, Yuejun Yao, Qing Wu, Feng Liu, Ruyi Zhou, Chaojie Zhu, Xinyuan Shen, Zheng-Wei Mao, Yuan Ding, Weilin Wang, Gianpietro Dotti, Jie Sun, Xiao Liang, Wei-Jia Fang, Peng Zhao, Hong-Jun Li, Zhen Gu
Lyophilized lymph nodes for improved delivery of chimeric antigen receptor T cells. Nature materials (2024)
Feng-Hua Wang, Ying Jin, Min Wang, Hui-Yan Luo, Wei-Jia Fang, Ying-Nan Wang, Yan-Xing Chen, Run-Jie Huang, Wen-Long Guan, Weiwei Xiao, Yu-Hong Li, Feng-Hua Wang, Xiao-Hua Hu, Yan-Qiao Zhang, Miao-Zhen Qiu, Lu-Lu Liu, Zi-Xian Wang, Chao Ren, De-Shen Wang, Dong-Sheng Zhang, Zhi-Qiang Wang, Wen-Ting Liao, Lin Tian, Qi Zhao, Rui-Hua Xu
Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial. Nature medicine (2024)
Jiaqi Shi, Wei Wu, Dong Chen, Ziyan Liao, Tao Sheng, Yanfang Wang, Yuejun Yao, Qing Wu, Feng Liu, Ruyi Zhou, Chaojie Zhu, Xinyuan Shen, Zheng-Wei Mao, Yuan Ding, Weilin Wang, Gianpietro Dotti, Jie Sun, Xiao Liang, Wei-Jia Fang, Peng Zhao, Hong-Jun Li, Zhen Gu
Lyophilized lymph nodes for improved delivery of chimeric antigen receptor T cells. Nature materials 23 (6) (2024)
Feng-Hua Wang, Ying Jin, Min Wang, Hui-Yan Luo, Wei-Jia Fang, Ying-Nan Wang, Yan-Xing Chen, Run-Jie Huang, Wen-Long Guan, Weiwei Xiao, Yu-Hong Li, Feng-Hua Wang, Xiao-Hua Hu, Yan-Qiao Zhang, Miao-Zhen Qiu, Lu-Lu Liu, Zi-Xian Wang, Chao Ren, De-Shen Wang, Dong-Sheng Zhang, Zhi-Qiang Wang, Wen-Ting Liao, Lin Tian, Qi Zhao, Rui-Hua Xu
Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial. Nature medicine 30 (4) (2024)
Feng-Hua Wang, Ying Jin, Min Wang, Hui-Yan Luo, Wei-Jia Fang, Ying-Nan Wang, Yan-Xing Chen, Run-Jie Huang, Wen-Long Guan, Weiwei Xiao, Yu-Hong Li, Feng-Hua Wang, Xiao-Hua Hu, Yan-Qiao Zhang, Miao-Zhen Qiu, Lu-Lu Liu, Zi-Xian Wang, Chao Ren, De-Shen Wang, Dong-Sheng Zhang, Zhi-Qiang Wang, Wen-Ting Liao, Lin Tian, Qi Zhao, Rui-Hua Xu
Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial. Nature medicine 30 (4) (2024)
Feng-Hua Wang, Ying Jin, Min Wang, Hui-Yan Luo, Wei-Jia Fang, Ying-Nan Wang, Yan-Xing Chen, Run-Jie Huang, Wen-Long Guan, Weiwei Xiao, Yu-Hong Li, Feng-Hua Wang, Xiao-Hua Hu, Yan-Qiao Zhang, Miao-Zhen Qiu, Lu-Lu Liu, Zi-Xian Wang, Chao Ren, De-Shen Wang, Dong-Sheng Zhang, Zhi-Qiang Wang, Wen-Ting Liao, Lin Tian, Qi Zhao, Rui-Hua Xu
Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial. Nature medicine 30 (4) (2024)
Jiaqi Shi, Wei Wu, Dong Chen, Ziyan Liao, Tao Sheng, Yanfang Wang, Yuejun Yao, Qing Wu, Feng Liu, Ruyi Zhou, Chaojie Zhu, Xinyuan Shen, Zheng-Wei Mao, Yuan Ding, Weilin Wang, Gianpietro Dotti, Jie Sun, Xiao Liang, Wei-Jia Fang, Peng Zhao, Hong-Jun Li, Zhen Gu
Lyophilized lymph nodes for improved delivery of chimeric antigen receptor T cells. Nature materials (2024)
Hangyu Zhang, Yiqing Ren, Feiyu Wang, Xiaoxuan Tu, Zhou Tong, Lulu Liu, Yi Zheng, Peng Zhao, Jinlin Cheng, Jianwen Li, Wei-Jia Fang, Xia Liu
The long-term effectiveness and mechanism of oncolytic virotherapy combined with anti-PD-L1 antibody in colorectal cancer patient. Cancer gene therapy (2024)
Qi Zhang, Ye Zhou, Lijie Song, Wei-Jia Fang, Meng Qiu, Yanhong Gu, Yang Yang, Jingdong Zhang, Jing Liu, Jian Li, Ming Lu, Tianxiao Gong, Xin Wang, Yan Li, Jun Yang, Yingjiang Ye, Lin Shen
China special issue on gastrointestinal tumor-improved survival after multidisciplinary team decision for patients with advanced gastrointestinal cancer: A multicenter, noninterventional, controlled study. International journal of cancer (2023)
Xianhua Fu, Jieer Ying, Liu Yang, Wei-Jia Fang, Weidong Han, Hanguang Hu, Suzhan Zhang, Ying Yuan
Dual targeted therapy with pyrotinib and trastuzumab for HER2-positive advanced colorectal cancer: A phase 2 trial. Cancer science (2022)
Jiawei Shi, Junwei Liu, Xiaoxuan Tu, Bin Li, Zhou Tong, Tian Wang, Yi Zheng, Hongyu Shi, Xun Zeng, Wei J Chen, Weiwei Yin, Wei-Jia Fang
Single-cell immune signature for detecting early-stage HCC and early assessing anti-PD-1 immunotherapy efficacy. Journal for immunotherapy of cancer 10 (1) (2022)
Feng-Hua Wang, Ming-Ming He, Jian Xiao, Yan-Qiao Zhang, Xiang-Lin Yuan, Wei-Jia Fang, Yan Zhang, Wei Wang, Xiao-Hua Hu, Zhi-Gang Ma, Yi-Chen Yao, Zhi-Xiang Zhuang, Yingying Shi, Jie-Er Ying, Ying Yuan, Qing-Feng Zou, Zeng Qing Guo, Xiang-Yuan Wu, Ying Jin, Zong-Jiong Mai, Zhi-Qiang Wang, Hong Qiu, Ying Guo, Si-Mei Shi, Shuang-Zhen Chen, Hui-Yan Luo, Dong-Sheng Zhang, Feng-Hua Wang, Yu-Hong Li, Rui-Hua Xu
A Randomized, Open-Label, Multicenter, Phase 3 Study of High-Dose Vitamin C Plus FOLFOX ± Bevacizumab versus FOLFOX ± Bevacizumab in Unresectable Untreated Metastatic Colorectal Cancer (VITALITY Study). Clinical cancer research : an official journal of the American Association for Cancer Research 28 (19) (2022)
Shu-Kui Qin, Zhendong Chen, Wei-Jia Fang, Zhenggang Ren, Ruocai Xu, Baek-Yeol Ryoo, Zhiqiang Meng, Yuxian Bai, Xiaoming Chen, Xiufeng Liu, Juxiang Xiao, Gwo Fuang Ho, Yimin Mao, Xin Wang, Jieer Ying, Jianfeng Li, Wenyan Zhong, Yu Zhou, Abby B Siegel, Chunyi Hao
Pembrolizumab Versus Placebo as Second-Line Therapy in Patients From Asia With Advanced Hepatocellular Carcinoma: A Randomized, Double-Blind, Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Xuanwen Bao, Qiong Li, Jinzhang Chen, Diyu Chen, Chanqi Ye, Xiao-Meng Dai, Yanfang Wang, Xin Li, Xiaoxiang Rong, Fei Cheng, Ming Jiang, Zheng Zhu, Yongfeng Ding, Rui Sun, Chuan Liu, Lingling Huang, Yuzhi Jin, Bin Li, Juan Lu, Wei Wu, Yixuan Guo, Wen-Guang Fu, Sarah Raye Langley, Vincent Tano, Wei-Jia Fang, Tiannan Guo, Jianpeng Sheng, Peng Zhao, Jian Ruan
Molecular Subgroups of Intrahepatic Cholangiocarcinoma Discovered by Single-Cell RNA Sequencing-Assisted Multiomics Analysis. Cancer immunology research 10 (7) (2022)
Hangyu Zhang, Xudong Zhu, Bin Li, Xiao-Meng Dai, Xuanwen Bao, Qihan Fu, Zhou Tong, Lulu Liu, Yi Zheng, Peng Zhao, Luan Ye, Zhihong Chen, Wei-Jia Fang, Lingxiang Ruan, Xinyu Jin
Development and validation of a meta-learning-based multi-modal deep learning algorithm for detection of peritoneal metastasis. International journal of computer assisted radiology and surgery 17 (10) (2022)
Dong Chen, Xuanwen Bao, Ruyi Zhang, Yongfeng Ding, Min Zhang, Benfeng Li, Hangyu Zhang, Xiaolin Li, Zhou Tong, Lulu Liu, Xiaohu Zhou, Saisai Wang, Xiaofei Cheng, Yi Zheng, Jian Ruan, Wei-Jia Fang, Peng Zhao
Depiction of the genomic and genetic landscape identifies CCL5 as a protective factor in colorectal neuroendocrine carcinoma. British journal of cancer 125 (7) (2021)
Xujun Zhang, Kefan Bi, Xiaoxuan Tu, Qiong Zhang, Qingyi Cao, Yan Liang, Ping Zeng, Lin Wang, Tianxing Liu, Wei-Jia Fang, Hongyan Diao
Interleukin-33 as an early predictor of cetuximab treatment efficacy in patients with colorectal cancer. Cancer medicine 10 (23) (2021)
Ruyi Zhang, Marco Puzzoni, Stefano Mariani, Yi Zheng, Nicole Liscia, Yixuan Guo, Clelia Donisi, Yu Liu, Valentino Impera, Wei-Jia Fang, Mario Scartozzi
Emerging treatment evolutions and integrated molecular characteristics of biliary tract cancers. Cancer science 112 (12) (2021)
Satoru Iwasa, Kei Muro, Satoshi Morita, Young Suk Park, Masato Nakamura, Masahito Kotaka, Tomohiro Nishina, Hiroshi Matsuoka, Joong Bae Ahn, Keun-Wook Lee, Yong Sang Hong, Sae Won Han, Sang Hee Cho, Dong-Sheng Zhang, Wei-Jia Fang, Li Bai, Xiang-Lin Yuan, Ying Yuan, Yasuhide Yamada, Junichi Sakamoto, Tae Won Kim
Impact of UGT1A1 genotype on the efficacy and safety of irinotecan-based chemotherapy in metastatic colorectal cancer. Cancer science 112 (11) (2021)
Xuanwen Bao, Run Shi, Tianyu Zhao, Yanfang Wang, Natasa Anastasov, Michael Rosemann, Wei-Jia Fang
Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels tumour heterogeneity plus M2-like tumour-associated macrophage infiltration and aggressiveness in TNBC. Cancer immunology, immunotherapy : CII 70 (1) (2020)
Yi Zheng, Tingting Wang, Xiaoxuan Tu, Yun Huang, Hangyu Zhang, Di Tan, Weiqin Jiang, Shunfeng Cai, Peng Zhao, Ruixue Song, Peilu Li, Nan Qin, Wei-Jia Fang
Gut microbiome affects the response to anti-PD-1 immunotherapy in patients with hepatocellular carcinoma. Journal for immunotherapy of cancer 7 (1) (2019)
Weiqin Jiang, Yifei Shen, Yongfeng Ding, Chuyu Ye, Yi Zheng, Peng Zhao, Lulu Liu, Zhou Tong, Linfu Zhou, Shuo Sun, Xingchen Zhang, Lisong Teng, Michael P Timko, Longjiang Fan, Wei-Jia Fang
A naive Bayes algorithm for tissue origin diagnosis (TOD-Bayes) of synchronous multifocal tumors in the hepatobiliary and pancreatic system. International journal of cancer 142 (2) (2017)